FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213080460> ?p ?o ?g. }

• W4213080460 endingPage "174844" @default.
• W4213080460 startingPage "174844" @default.
• W4213080460 abstract "Over the past few years, the antitumor activity exhibited by 5-caffeylquinic acid (5-CQA), especially its inhibitory effect on hepatocellular carcinoma (HCC) proliferation and metastasis, has been recognized as a new research hotspot. However, impacted by the weak antitumor toxicity of 5-CQA, its clinical application has been limited. In this study, the antitumor effect arising from 5-CQA on HCC cells was evaluated through cell viability assay. In addition, proteomics, flow cytometry, qRT-PCR and western blotting were adopted to investigate the drug resistance mechanism of HCC cells to 5-CQA. As indicated by the results, 5-CQA significantly inhibited the proliferation of HCC cell lines MHCC97H and HCCLM3 with IC5048 h of 546.8 μM and 452 μM, respectively. According to the in-depth studies, the abnormal activation of HIF-1α/glucose transporters/glycolysis pathway of 5-CQA could be a key molecular mechanism leading to drug resistance of HCC cells. Thus, this study found that glucose starvation, glucose analogue 2-DG, hexokinase inhibitor bromopyruvic acid and PKM2 inhibitor compound 3k inhibited HCC cell proliferation in synergy with 5-CQA. Furthermore, though the 5-CQA derivatives methyl chlorogenate (MCGA) and 3,5-dicaffeoylquinic acid (3,5-diCQA) exhibited more potent antiproliferation activity in HCC cells than 5-CQA, they also up-regulated the expression of GLUT1/3, whereas they had no effect on hepatocytes. To be specific, under low-glucose culture conditions, the order of sensitivity of HCC cells to CQAs was 3,5-diCQA > MCGA > 5-CQA. In brief, the above results revealed that intervention in glucose metabolism can facilitate the effects of 5-CQA and its derivatives for treating HCC." @default.
• W4213080460 created "2022-02-24" @default.
• W4213080460 creator A5002432969 @default.
• W4213080460 creator A5009753049 @default.
• W4213080460 creator A5041374203 @default.
• W4213080460 creator A5050213595 @default.
• W4213080460 creator A5052267876 @default.
• W4213080460 creator A5071217859 @default.
• W4213080460 creator A5074327970 @default.
• W4213080460 creator A5078330016 @default.
• W4213080460 creator A5079412241 @default.
• W4213080460 creator A5083177291 @default.
• W4213080460 creator A5089488563 @default.
• W4213080460 creator A5091548233 @default.
• W4213080460 date "2022-04-01" @default.
• W4213080460 modified "2023-10-14" @default.
• W4213080460 title "Inhibition of abnormally activated HIF-1α-GLUT1/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivatives" @default.
• W4213080460 cites W107774963 @default.
• W4213080460 cites W1503060668 @default.
• W4213080460 cites W1843229613 @default.
• W4213080460 cites W1864453987 @default.
• W4213080460 cites W1949652406 @default.
• W4213080460 cites W1964423256 @default.
• W4213080460 cites W1997358952 @default.
• W4213080460 cites W2011896793 @default.
• W4213080460 cites W2018024152 @default.
• W4213080460 cites W2020621917 @default.
• W4213080460 cites W2026439698 @default.
• W4213080460 cites W2033363296 @default.
• W4213080460 cites W2037706400 @default.
• W4213080460 cites W2042317840 @default.
• W4213080460 cites W2055553698 @default.
• W4213080460 cites W2072451938 @default.
• W4213080460 cites W2087408461 @default.
• W4213080460 cites W2092717729 @default.
• W4213080460 cites W2094156327 @default.
• W4213080460 cites W2094685285 @default.
• W4213080460 cites W2097259163 @default.
• W4213080460 cites W2116159404 @default.
• W4213080460 cites W2116680956 @default.
• W4213080460 cites W2124679671 @default.
• W4213080460 cites W2130304025 @default.
• W4213080460 cites W2132955042 @default.
• W4213080460 cites W2158986206 @default.
• W4213080460 cites W2272954896 @default.
• W4213080460 cites W2290119977 @default.
• W4213080460 cites W2294579280 @default.
• W4213080460 cites W2516701631 @default.
• W4213080460 cites W2592943812 @default.
• W4213080460 cites W2605131570 @default.
• W4213080460 cites W2607502289 @default.
• W4213080460 cites W2621333085 @default.
• W4213080460 cites W2778275005 @default.
• W4213080460 cites W2799933121 @default.
• W4213080460 cites W2808605581 @default.
• W4213080460 cites W2897214576 @default.
• W4213080460 cites W2898585370 @default.
• W4213080460 cites W2902648931 @default.
• W4213080460 cites W2910207635 @default.
• W4213080460 cites W2910730299 @default.
• W4213080460 cites W2912201468 @default.
• W4213080460 cites W2913384788 @default.
• W4213080460 cites W2924517120 @default.
• W4213080460 cites W2932691690 @default.
• W4213080460 cites W2985781565 @default.
• W4213080460 cites W2991531722 @default.
• W4213080460 cites W3004423058 @default.
• W4213080460 cites W3034819388 @default.
• W4213080460 cites W3083314342 @default.
• W4213080460 cites W3092083132 @default.
• W4213080460 cites W3124095497 @default.
• W4213080460 cites W3126478543 @default.
• W4213080460 cites W3157657766 @default.
• W4213080460 cites W3164023642 @default.
• W4213080460 doi "https://doi.org/10.1016/j.ejphar.2022.174844" @default.
• W4213080460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35189090" @default.
• W4213080460 hasPublicationYear "2022" @default.
• W4213080460 type Work @default.
• W4213080460 citedByCount "5" @default.
• W4213080460 countsByYear W42130804602022 @default.
• W4213080460 countsByYear W42130804602023 @default.
• W4213080460 crossrefType "journal-article" @default.
• W4213080460 hasAuthorship W4213080460A5002432969 @default.
• W4213080460 hasAuthorship W4213080460A5009753049 @default.
• W4213080460 hasAuthorship W4213080460A5041374203 @default.
• W4213080460 hasAuthorship W4213080460A5050213595 @default.
• W4213080460 hasAuthorship W4213080460A5052267876 @default.
• W4213080460 hasAuthorship W4213080460A5071217859 @default.
• W4213080460 hasAuthorship W4213080460A5074327970 @default.
• W4213080460 hasAuthorship W4213080460A5078330016 @default.
• W4213080460 hasAuthorship W4213080460A5079412241 @default.
• W4213080460 hasAuthorship W4213080460A5083177291 @default.
• W4213080460 hasAuthorship W4213080460A5089488563 @default.
• W4213080460 hasAuthorship W4213080460A5091548233 @default.
• W4213080460 hasConcept C134018914 @default.
• W4213080460 hasConcept C1491633281 @default.
• W4213080460 hasConcept C153911025 @default.
• W4213080460 hasConcept C181199279 @default.

• next